SVMPharma has recently collected real-world data in the UK (ICE-UK) and Portugal (ICE-PT) for DMO patients looking at the effectiveness of fluocinolone acetonide intravitreal implant (LUVIEN®). This has led to successful outcomes leading to multiple publications to presentations in a major European congress in 2017 and 2018 Chart notes Treatment data Align with KOLs SVMPharma’s […]

Patients with CF are susceptible to recurrent chronic respiratory tract infections, which can exacerbate and increase the risk of death and morbidity. In this study we look at the real world effectiveness of the inhaled antibiotics aztreonam lysine (CAYSTON®) in routine clinical practice. Data from the study was presented at the European Cystic Fibrosis Society […]

SVMPharma’s real-world evidence helped deliver a real-world study looking at the clinical outcomes of triptorelin vs other LHRH agonists (LHRHa) in clinical practice for prostate cancer patients. Our real-world evidence helped show a significant reduction in healthcare resource utilisation for the NHS as well as maintenance in PSA control (a biomarker in prostate cancer) when switching to a 6-monthly formulation […]